Přejít k obsahu
Merck
  • Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines.

Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines.

Oncotarget (2017-12-22)
Valentina Fustaino, Dario Presutti, Teresa Colombo, Beatrice Cardinali, Giuliana Papoff, Rossella Brandi, Paola Bertolazzi, Giovanni Felici, Giovina Ruberti
ANOTACE

Increasing evidence points to a key role played by epithelial-mesenchymal transition (EMT) in cancer progression and drug resistance. In this study, we used

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
Erlotinib hydrochloride